Humanigen Inc (HGENQ)
OTCMKTS: HGENQ · Delayed Price · USD
0.0002
0.00 (0.00%)
Jul 2, 2024, 4:00 PM EDT - Market closed
Humanigen Market Cap
Humanigen has a market cap or net worth of $23.82 thousand as of July 2, 2024. Its market cap has decreased by -99.93% in one year.
Market Cap
23.82K
Enterprise Value
-3.07M
1-Year Change
-99.93%
Ranking
n/a
Category
Stock Price
$0.00
Market Cap Chart
Since January 31, 2013, Humanigen's market cap has decreased from $61.70M to $23.82K, a decrease of -99.96%. That is a compound annual growth rate of -52.75%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 25, 2023 | 4.30M | -69.93% |
| Dec 30, 2022 | 14.30M | -93.98% |
| Dec 31, 2021 | 237.40M | -73.72% |
| Dec 31, 2020 | 903.30M | 1,533.45% |
| Dec 31, 2019 | 55.30M | -37.09% |
| Dec 31, 2018 | 87.90M | 1,365.00% |
| Dec 29, 2017 | 6.00M | -89.67% |
| Dec 30, 2016 | 58.10M | -40.29% |
| Dec 31, 2015 | 97.30M | 70.40% |
| Dec 31, 2014 | 57.10M | -60.76% |
| Dec 31, 2013 | 145.50M | 135.82% |
| Jan 31, 2013 | 61.70M | - |
View and export this data all the way back to 2013.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly | 869.02B |
| Novo Nordisk | 643.34B |
| UnitedHealth Group | 455.27B |
| Johnson & Johnson | 352.43B |
| Merck & Co. | 323.95B |
| AbbVie | 300.85B |
| AstraZeneca | 241.65B |
| Novartis AG | 208.44B |